- Injectable cabotegravir (CAB_LA), a ground-breaking HIV prevention injection, has been made available in Zimbabwe for pre-exposure prophylaxis (PrEP).
- This novel biological technique provides a practical and effective means of preventing HIV transmission in those who are significantly at risk. For people wanting protection against the virus, CAB_LA is a more manageable choice than the standard daily regimen of medications necessary for PrEP.
- It is taken once every two months. Prominent physician Dr. Misheck Ruwende announced the injection’s release via X. Public hospitals do not presently offer the injection, however it is currently offered at New Start Centers through Population Solutions for Health.
- People in Zimbabwe are excited and curious about CAB_LA, and social media platforms are a hive of conversation and viewpoints since its launch.
- The HIV prevention injection is still not widely available, and it’s unclear yet what standards are being applied to choose who gets the shot.
